跳至主要内容
临床试验/CTRI/2022/04/041912
CTRI/2022/04/041912尚未招募不适用

Development of scale for the assessment of strength of Satva and to evaluate its influence on RÄjayaká¹£mÄ with special reference to Pulmonary Tuberculosis

Institute of Medical Science Banaras Hindu University Varanasi Uttar Pradesh India1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2022年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
75
试验地点
1
主要终点
To evaluate the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis.

研究概览

简要总结

This study is a single group prospective observational study to evaluate the strength of satva and its role in Pulmonary Tuberculosis. The primary outcome will association of the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis. The secondary outcome will be the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • •1.Confirmed pulmonary tuberculosis patients irrespective of gender 2.Patients with well controlled comorbid conditions 3.Age group between 18-70 years.

排除标准

  • •1.Not willing to complete the consent process as describe in proforma.
  • •2.Inability to comply with study procedures and methods.
  • •3.HIV patients.

结局指标

主要结局

To evaluate the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis.

时间窗: 1.5yr

次要结局

  • To evaluate the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.(1.5 yr)

研究者

发起方
Institute of Medical Science Banaras Hindu University Varanasi Uttar Pradesh India
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验